• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Flotek Reports 95% Gross Profit Growth in Third Quarter

    11/4/25 4:08:00 PM ET
    $FTK
    Major Chemicals
    Industrials
    Get the next $FTK alert in real time by email

    HOUSTON, Nov. 4, 2025 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK), a leader in innovative energy solutions, today announced its financial results for the quarter and nine-months ended September 30, 2025, which reflect continued successful execution of its transformational strategy and robust growth across its two segments.

    Flotek Industries, Inc. (PRNewsfoto/Flotek Industries, Inc.)

    Financial Summary (in thousands, except 'per share' amounts)



    Three Months Ended September 30,



    Nine Months Ended September 30,



    2025



    2024



    % Change



    2025



    2024



    % Change

























    Total Revenues

    $      56,031



    $      49,742



    13 %



    $    169,743



    $    136,267



    25 %

    Gross Profit

    $      17,783



    $         9,119



    95 %



    $      44,639



    $      27,108



    65 %

    Net Income

    $      20,355



    $         2,532



    704 %



    $      27,503



    $         6,068



    353 %

    Diluted Income Per Share

    $           0.53



    $           0.08



    563 %



    $           0.78



    $           0.20



    290 %

    Adjusted EBITDA (1)

    $      11,721



    $         4,840



    142 %



    $      28,953



    $      13,303



    118 %

    Highlights:

    (all comparisons versus Q3 2024 unless noted) 

    • Total revenues increased 13% driven largely by the Data Analytics segment, as the mobile gas conditioning assets acquired in the second quarter of 2025 (the "Acquired Assets") generated $6.1 million of third quarter 2025 revenue.
    • Data Analytics segment revenues grew to 16% of total revenues, up from 5% in third quarter 2024, helping to deliver total Company gross profit margin of 32%, as compared to 18% in the year-ago quarter. 
    • Data Analytics segment gross profit margin totaled 71% during the third quarter of 2025 as compared to 44% during the year-ago quarter.
    • Net income totaled $20.4 million, or $0.53 per diluted share, compared to $2.5 million, or $0.08 per diluted share, in the year-ago quarter.  Third quarter 2025 net income included a $12.6 million tax benefit, as further discussed below. 
    • Adjusted EBITDA(1) increased by 142% to $11.7 million, compared to $4.8 million in the year-ago quarter, representing the twelfth consecutive quarter of growth.
    • On October 29, 2025 Flotek announced that the XSPCTTM analyzer was the first optical spectrometer to comply with GPA 2172 (O&G Custody Transfer Standard)

    2025 Guidance Update: Based on strong year-to-date operational performance and the outlook for the fourth quarter, the Company is increasing its 2025 guidance ranges as follows ($MMs):



    Previous Guidance

    Revised Guidance

    Total Revenues

    $200-$220

    $220-$225

    Adjusted EBITDA (2)

    $34-$39

    $35-$40

    Management Commentary

    Chief Executive Officer Dr. Ryan Ezell commented, "Flotek delivered an outstanding third quarter, highlighted by reporting total Company gross profit margin of 32%. Throughout the quarter, we continued successfully executing our corporate strategy to transform Flotek into a data-driven technology enterprise. Our Data Analytics segment delivered quarterly revenue comparable to the full year 2024, reflecting accelerated adoption of our advanced analytics solutions supporting the industrial pivot within the energy infrastructure sector. Our Chemistry Technologies segment continued to expand market share, driven by strong demand for our innovative chemical solutions that enhance reservoir performance. Through the first three quarters of 2025, Chemistry segment revenues were 17% higher year-over-year. Our third quarter results underscore the strength in each of our segments and demonstrate our disciplined execution and steadfast commitment to creating value for our customers and shareholders even in challenging market conditions."

    Segment Revenue Summary (in thousands)



    Three Months Ended September 30,



    Nine Months Ended September 30,



    2025



    2024



    % Change



    2025



    2024



    % Change

























    Chemistry Technologies:























    External Revenues

    $             20,221



    $             14,097



    43 %



    $ 64,773



    $      42,143



    54 %

    Related Party Revenues

    26,956



    32,977



    (18) %



    87,562



    87,732



    — %

    Total

    $             47,177



    $             47,074



    — %



    $  152,335



    $    129,875



    17 %

























    Data Analytics:























    Product Revenues

    $               1,694



    $               1,681



    1 %



    $    5,176



    $         3,920



    32 %

    Service Revenues (3)

    7,160



    987



    625 %



    12,232



    2,472



    395 %

    Total

    $               8,854



    $               2,668



    232 %



    $ 17,408



    $         6,392



    172 %

    Revenues:

    • Chemistry Technologies: The segment grew external revenue 43% as compared to the year-ago quarter. This growth reflects Flotek's ability to continue to capture market share despite a 25% year-over-year decline in North American frac fleets(4), indicating strong demand for our specialized chemistry solutions. However, related party chemistry purchases were impacted negatively by reduced fleet count utilization.
    • Data Analytics: The segment achieved a 232% revenue increase as compared to the year-ago quarter, with service revenues growing 625% to $7.2 million, underscoring the growing market demand for Flotek's data-driven solutions that enhance operational efficiency for clients.  Third quarter 2025 service revenues include approximately $6.1 million related to the Acquired Assets. 

    Gross Profit: The Company generated gross profit of $17.8 million during the third quarter of 2025 compared to $9.1 million during the third quarter of 2024. The 95% increase in third quarter 2025 gross profit was driven by a 232% increase in high-margin Data Analytics revenue. Additionally, the reduction in related party chemistry sales, as compared to the year-ago quarter, resulted in a 28% increase in revenues attributable to the minimum chemistry purchase requirement contained in the Company's long-term supply agreement with ProFrac. Gross profit as a percentage of revenue totaled 32% in the third quarter of 2025 as compared to 18% in the year-ago period.

    Selling, General and Administrative ("SG&A") Expense: SG&A expense totaled $7.4 million for the third quarter of 2025, or 13% as a percentage of revenues, compared to $5.7 million during the third quarter of 2024, or 11% as a percentage of revenues. The increase in SG&A expenses during the third quarter of 2025 was primarily the result of higher professional fees and personnel costs including non-cash stock compensation costs.

    Net Income: In the third quarter of 2025, Flotek reported net income of $20.4 million, or $0.53 per diluted share, as compared to $2.5 million, or $0.08 per diluted share, in the year-ago quarter. Net income during the third quarter of 2025 included a $12.6 million tax benefit related to previously reserved deferred tax assets. While the current quarter impact of the partial release of the valuation allowance is non-cash, it is a positive indication of the Company's outlook for generating future income from which it could utilize its deferred tax assets.

    Adjusted EBITDA(1) (Non-GAAP): Adjusted EBITDA(1) was $11.7 million in the third quarter of 2025 as compared to $4.8 million in the third quarter of 2024. This marks the 12th consecutive quarter of Adjusted EBITDA(1) improvement.

    PWRtekTM Update: During the third quarter of 2025, revenues attributable to the Acquired Assets totaled $6.1 million with gross profit as a percentage of revenue totaling approximately 89%. As of September 30, 2025, all the Acquired Assets were in service and the Company expects fourth quarter and full year 2025 PWRtek revenues to total approximately $6.8 million and $16.1 million, respectively. Acquisition expenses related to the asset acquisition during the third quarter and nine-month periods of 2025 totaled $0.2 million and $4.4 million, respectively.

    (1)

    Represents a non-GAAP measure, see the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" table in this release for more information about this measure, including reconciliations to the most comparable GAAP measures.





    (2)

    A non-GAAP financial measure. See the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" table  in this release for more information about this measure. We are unable to reconcile this forward-looking non-GAAP financial measure to the most directly comparable GAAP financial measure without unreasonable efforts, as we are unable to predict with a reasonable degree of certainty the impact of certain items that would be expected to impact the GAAP financial measure, including, among other items, certain stock-based compensation costs, interest costs related to fluctuations in borrowings outstanding under the Company's asset based loan and the impact of the revaluation of certain liabilities, which is based upon our future stock price. These items do not impact the non-GAAP financial measure.





    (3)

    Service revenues during the three- and nine-month 2025 periods include $6.1 million and $9.3 million respectively, related to PWRtek rental revenues.





    (4)

    Comparison according to Primary Vision Active U.S. Fracturing Operation Fleet Counts on 9/26/2025 of 179 compared to 9/28/2024 of 238

    Conference Call Details

    The Company plans to host its earnings conference call on Wednesday, November 5, 2025, at 9:00 a.m. CDT (10:00 a.m. EDT).

    Participants may access the call through Flotek's website at https://ir.flotekind.com under the "News & Events" section, by telephone toll free at 1-800-836-8184 (international toll: 1-646-357-8785), or by using the following link to access the audience view of the webcast at https://app.webinar.net/NLao0z9kmlg approximately five minutes prior to the start of the call. Following the conclusion of the conference call, a recording of the call will be available on the Company's website.

    About Flotek Industries, Inc.

    Flotek Industries, Inc. is a leading chemistry and data technology company focused on servicing the Energy industry. The Company's technologies leverage near real-time data to deliver innovative solutions to maximize customer returns. Flotek has an intellectual property portfolio of over 130 patents, over 20 years of field and laboratory data, and a global presence in more than 59 countries.

    Flotek has established collaborative partnerships focused on sustainable and optimized chemistry and data solutions, aiming to reduce the environmental impact of energy on land, air, water and people.

    Flotek is based in Houston, Texas and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK." For additional information, please visit www.flotekind.com.

    Forward-Looking Statements

    Certain statements set forth in this press release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.'s business, financial condition, results of operations and prospects. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this press release. Although forward-looking statements in this press release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Further information about the risks and uncertainties that may impact the Company are set forth in the Company's most recent filing with the Securities and Exchange Commission on Form 10-K (including, without limitation, in the "Risk Factors" section thereof), and in the Company's other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this press release.

     

    FLOTEK INDUSTRIES, INC.

    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

    (in thousands, except share data)





    September 30, 2025



    December 31, 2024

    ASSETS







    Current assets:







    Cash and cash equivalents

    $                          4,603



    $                          4,404

    Restricted cash

    103



    102

    Accounts receivable, net of allowance for credit losses of $716 and $447 at

    September 30, 2025 and December 31, 2024, respectively

    26,767



    17,386

    Accounts receivable, related party, net of allowance for credit losses of $0 at

    each of September 30, 2025 and December 31, 2024, respectively

    44,831



    52,370

    Inventories, net

    13,232



    13,303

    Other current assets

    2,305



    2,952

    Current contract asset

    8,179



    5,939

    Total current assets

    100,020



    96,456

    Long-term contract asset

    56,655



    63,105

    Property and equipment, net

    20,822



    6,178

    Right-of-use assets

    3,266



    3,326

    Deferred tax assets, net

    30,351



    51

    Other long-term assets

    1,573



    1,680

    TOTAL ASSETS

    $                      212,687



    $                      170,796









    LIABILITIES AND STOCKHOLDERS' EQUITY







    Current liabilities:







    Accounts payable

    $                        35,073



    $                        38,073

    Accrued liabilities

    4,925



    5,912

    Accrued liabilities, related party

    7,248



    —

    Income taxes payable

    197



    48

    Interest payable, related party

    1,008



    —

    Current portion of operating lease liabilities

    1,216



    1,486

    Current portion of finance lease liabilities

    149



    —

    Asset-based loan

    6,662



    4,789

    Current portion of long-term debt

    —



    60

    Total current liabilities

    56,478



    50,368

    Deferred revenue, long-term

    —



    14

    Note payable - related party

    39,560



    —

    Long-term operating lease liabilities

    5,887



    6,514

    Long-term finance lease liabilities

    264



    —

    TOTAL LIABILITIES

    102,189



    56,896

    Commitments and contingencies







    Stockholders' equity:







    Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares

          issued and outstanding

    —



    —

    Common stock, $0.0001 par value, 240,000,000 shares authorized;

    31,102,241 shares issued and 29,989,657 shares outstanding at September

    30, 2025; 30,938,073 shares issued and 29,826,508 shares outstanding at

    December 31, 2024

    3



    3

    Additional paid-in capital

    433,939



    464,620

    Accumulated other comprehensive income

    109



    251

    Accumulated deficit

    (288,805)



    (316,308)

    Treasury stock, at cost; 1,112,584 and 1,111,565 shares at September 30,

    2025 and December 31, 2024, respectively

    (34,748)



    (34,666)

    Total stockholders' equity

    110,498



    113,900

    TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

    $                      212,687



    $                      170,796

     

    FLOTEK INDUSTRIES, INC.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (in thousands, except per share data)





    Three Months Ended

    September 30,



    Nine Months Ended

    September 30,



    2025



    2024



    2025



    2024

    Revenue:















    Revenue from external customers

    $    22,941



    $    16,565



    $    72,546



    $    47,935

    Revenue from related party

    33,090



    33,177



    97,197



    88,332

    Total revenues

    56,031



    49,742



    169,743



    136,267

    Cost of goods sold

    38,248



    40,623



    125,104



    109,159

    Gross profit

    17,783



    9,119



    44,639



    27,108

    Operating costs and expenses:















    Selling, general, and administrative

    7,384



    5,714



    20,462



    18,079

    Asset acquisition expenses

    167



    —



    4,362



    —

    Depreciation

    581



    220



    1,207



    662

    Research and development

    549



    462



    1,359



    1,349

    Gain on sale of property and equipment

    —



    —



    (7)



    (34)

    Total operating costs and expenses

    8,681



    6,396



    27,383



    20,056

    Income from operations

    9,102



    2,723



    17,256



    7,052

    Other income (expense):















    Interest expense

    (1,351)



    (256)



    (2,563)



    (842)

    Other income (expense), net

    (8)



    102



    279



    151

    Total other expense

    (1,359)



    (154)



    (2,284)



    (691)

    Income before income taxes

    7,743



    2,569



    14,972



    6,361

    Income tax benefit (expense)

    12,612



    (37)



    12,531



    (293)

    Net income

    $    20,355



    $       2,532



    $    27,503



    $       6,068

















    Income per common share:













    Basic

    $         0.57



    $         0.09



    $         0.83



    $         0.21

    Diluted

    $         0.53



    $         0.08



    $         0.78



    $         0.20

















    Weighted average common shares:















    Weighted average common shares used in

     computing basic income per common share

    35,868



    29,613



    33,189



    29,498

    Weighted average common shares used in

     computing diluted income per common share

    38,137



    30,897



    35,420



    30,655

     

    FLOTEK INDUSTRIES, INC.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (in thousands)





    Nine Months Ended September 30,



    2025



    2024

    Cash flows from operating activities:







    Net income

    $               27,503



    $                 6,068

    Adjustments to reconcile net income to net cash provided by operating activities:







    Change in fair value of contingent consideration

    (127)



    (46)

    Amortization of contract assets

    4,210



    4,341

    Depreciation

    1,207



    662

    Amortization of deferred financing costs

    252



    243

    Provision for credit losses, net of recoveries

    555



    121

    Provision for excess and obsolete inventory

    307



    626

    Gain on sale of property and equipment

    (7)



    (34)

    Non-cash lease expense

    840



    1,661

    Stock compensation expense

    1,706



    915

    Deferred income tax (benefit) expense

    (12,773)



    233

    Changes in current assets and liabilities:







    Accounts receivable

    (9,936)



    1,346

    Accounts receivable, related party

    (10,013)



    (12,495)

    Inventories

    462



    (532)

    Income tax receivable

    (32)



    —

    Other assets

    724



    849

    Accounts payable

    (3,000)



    5,690

    Accrued liabilities

    (874)



    (1,730)

    Operating lease liabilities

    (1,204)



    (2,002)

    Income taxes payable

    149



    9

    Interest payable, related party

    1,008



    —

    Net cash provided by operating activities

    957



    5,925

    Cash flows from investing activities:







    Capital expenditures

    (1,697)



    (491)

    Proceeds from sale of assets

    7



    34

    Net cash used in investing activities

    (1,690)



    (457)

    Cash flows from financing activities:







    Payments on long term debt

    (60)



    (135)

    Proceeds from asset-based loan

    147,000



    122,600

    Payments on asset-based loan

    (145,127)



    (128,666)

    Payment of asset-based loan origination costs

    (150)



    (164)

    Payment of note payable issuance costs

    (480)



    —

    Payment of issuance costs of stock warrants

    (653)



    —

    Payments to tax authorities for shares withheld from employees

    (82)



    (30)

    Proceeds from issuance of stock under Employee Stock Purchase Plan

    113



    88

    Proceeds from issuance of stock from stock option exercises

    574



    —

    Payments for finance leases

    (60)



    (22)

    Net cash provided by (used in) financing activities

    1,075



    (6,329)

    Effect of changes in exchange rates on cash and cash equivalents

    (142)



    6

    Net change in cash and cash equivalents and restricted cash

    200



    (855)

    Cash and cash equivalents at the beginning of period

    4,404



    5,851

    Restricted cash at the beginning of period

    102



    102

    Cash and cash equivalents and restricted cash at beginning of period

    4,506



    5,953

    Cash and cash equivalents at end of period

    4,603



    4,997

    Restricted cash at the end of period

    103



    101

    Cash and cash equivalents and restricted cash at end of period

    $                 4,706



    $                 5,098

     

    FLOTEK INDUSTRIES, INC.

    UNAUDITED RECONCILIATION OF NON-GAAP ITEMS AND NON-CASH ITEMS IMPACTING EARNINGS

    (in thousands)





    Three Months Ended

    September 30,



    Nine Months Ended

    September 30,



    Twelve

    Months Ended

    December 31,



    2025



    2024



    2025



    2024



    2024





















    Net income

    $        20,355



    $          2,532



    $    27,503



    $      6,068



    $             10,498

    Interest expense

    1,351



    256



    2,563



    842



    1,095

    Income tax (benefit) expense

    (12,612)



    37



    (12,531)



    293



    649

    Depreciation and amortization

    581



    220



    1,207



    662



    891

    EBITDA (Non-GAAP) (1)

    $          9,675



    $          3,045



    $    18,742



    $      7,865



    $             13,133

    Stock compensation expense

    569



    272



    1,706



    915



    1,366

    Severance and retirement

    16



    —



    67



    32



    39

    Contingent liability revaluation

    —



    (19)



    (127)



    (46)



    71

    Gain on disposal of asset

    —



    —



    (7)



    (34)



    (124)

    Amortization of contract asset (2)

    1,294



    1,592



    4,210



    4,341



    5,612

    Non-Recurring professional fees (3)

    167



    (50)



    4,362



    230



    230

    Adjusted EBITDA (Non-GAAP) (1)

    $        11,721



    $          4,840



    $    28,953



    $    13,303



    $             20,327



    (1)

    Management believes that EBITDA and Adjusted EBITDA for the three and nine months ended September 30, 2025 and 2024, and for the twelve months ended December 31, 2024 are useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods.  Management views the adjustments made to net income for certain non-cash or non-recurring items noted above to be outside of the Company's normal operating results.  Management analyzes operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the business and cash flow from continuing operations, and to establish financial, compensation and operational objectives. In addition, the Company believes that Adjusted EBITDA provides investors, creditors and analysts with a clearer view of the Company's leverage profile and debt service capacity, enhancing comparability and augmenting the ability of investors, creditors and analysts to make investment decisions based upon liquidity.

    (2)

    The Company's contract assets arose from fixed, non-refundable consideration in the form of convertible notes issued by the Company to ProFrac in connection with the entry into the ProFrac Agreement and are amortized as a reduction of revenue over the contract term. While the GAAP presentation reduces revenue, these amounts economically represent the cost of acquiring the ProFrac Agreement, similar to commissions, marketing spend or other customer acquisition expenses. Accordingly, the Company's management treats the amortization of contract assets similar to a non-cash expense added-back to arrive at Adjusted EBITDA to more accurately reflect the recurring cash impact of the transaction and to maintain comparability with the treatment of other amortization costs and comparability of the Company's results with competitors that may not report amortization of contract assets. The Company believes that it is important for investors to understand that under GAAP, the amortization of contract assets is not an expense and instead reduces revenue.

    (3)

    Includes $0.2 million and $4.4 million of expenses related to Asset Acquisition for the three and nine months ended September 30, 2025, respectively.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/flotek-reports-95-gross-profit-growth-in-third-quarter-302604604.html

    SOURCE Flotek Industries, Inc.

    Get the next $FTK alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FTK

    DatePrice TargetRatingAnalyst
    8/6/2025$16.00Market Perform → Outperform
    Northland Capital
    6/17/2025$16.00Market Perform
    Northland Capital
    6/12/2025$19.00Buy
    Alliance Global Partners
    7/25/2024$6.50Buy
    ROTH MKM
    4/29/2024$7.00Buy
    Alliance Global Partners
    7/1/2021$2.50Outperform
    Noble Capital Markets
    More analyst ratings

    $FTK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wilks Matthew bought $190,535 worth of shares (13,442 units at $14.17) (SEC Form 4)

    4 - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Issuer)

    5/16/25 4:48:21 PM ET
    $FTK
    Major Chemicals
    Industrials

    Amendment: Director Wilks Matthew bought $1,650,912 worth of shares (136,324 units at $12.11) (SEC Form 4)

    4/A - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Issuer)

    5/15/25 4:16:07 PM ET
    $FTK
    Major Chemicals
    Industrials

    Director Wilks Matthew bought $1,650,912 worth of shares (136,324 units at $12.11) (SEC Form 4)

    4 - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Issuer)

    5/13/25 6:12:48 PM ET
    $FTK
    Major Chemicals
    Industrials

    $FTK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Flotek Reports 95% Gross Profit Growth in Third Quarter

    HOUSTON, Nov. 4, 2025 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK), a leader in innovative energy solutions, today announced its financial results for the quarter and nine-months ended September 30, 2025, which reflect continued successful execution of its transformational strategy and robust growth across its two segments. Financial Summary (in thousands, except 'per share' amounts) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 % Change 2025 2024 % Change Total Revenues $      56,031 $      49,742 13 % $    169,74

    11/4/25 4:08:00 PM ET
    $FTK
    Major Chemicals
    Industrials

    Flotek's 'XSPCT ™' Custody Transfer Unit Becomes the First Optical Spectrometer to Meet GPA 2172 Standard

    HOUSTON, Oct. 29, 2025 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek") (NYSE:FTK) has achieved a historic milestone in natural gas measurement. Its XSPCT optical spectrometer is the first optical instrument to achieve the stringent reproducibility and repeatability requirements of GPA 2172 (API 14.5), the oil and gas industry standard for accurate custody transfer. The XSPCT measurement unit is designed to enable more accurate volume and quality data and greater transparency for royalty owners, operators and midstream companies than traditional methods. We believe the XSPCT

    10/29/25 4:15:00 PM ET
    $FTK
    Major Chemicals
    Industrials

    Flotek Announces Third Quarter 2025 Earnings Release and Conference Call Schedule

    HOUSTON, Oct. 7, 2025 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK) today announced the Company's schedule for releasing its third quarter 2025 financial and operating results.    The Company plans to issue its third quarter 2025 financial and operating results press release after market close on Tuesday, November 4, 2025, and plans to host its earnings conference call on Wednesday, November 5, 2025, at 9:00 a.m. Central (10:00 a.m. Eastern). The press release will be posted on the Company's website at https://ir.flotekind.com/press-releases. P

    10/7/25 4:05:00 PM ET
    $FTK
    Major Chemicals
    Industrials

    $FTK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Flotek Industries upgraded by Northland Capital with a new price target

    Northland Capital upgraded Flotek Industries from Market Perform to Outperform and set a new price target of $16.00

    8/6/25 8:35:15 AM ET
    $FTK
    Major Chemicals
    Industrials

    Northland Capital initiated coverage on Flotek Industries with a new price target

    Northland Capital initiated coverage of Flotek Industries with a rating of Market Perform and set a new price target of $16.00

    6/17/25 9:01:40 AM ET
    $FTK
    Major Chemicals
    Industrials

    Alliance Global Partners initiated coverage on Flotek Industries with a new price target

    Alliance Global Partners initiated coverage of Flotek Industries with a rating of Buy and set a new price target of $19.00

    6/12/25 9:11:08 AM ET
    $FTK
    Major Chemicals
    Industrials

    $FTK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, GC and Secretary Blakeway Amy E. covered exercise/tax liability with 3,935 shares and converted options into 6,000 shares, increasing direct ownership by 11% to 20,950 units (SEC Form 4)

    4 - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Issuer)

    11/3/25 6:06:34 PM ET
    $FTK
    Major Chemicals
    Industrials

    Chief Financial Officer Clement James Bond covered exercise/tax liability with 9,838 shares and converted options into 15,000 shares, increasing direct ownership by 5% to 100,601 units (SEC Form 4)

    4 - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Issuer)

    11/3/25 6:01:53 PM ET
    $FTK
    Major Chemicals
    Industrials

    CEO Ezell Ryan Gillis covered exercise/tax liability with 19,675 shares and converted options into 30,000 shares, increasing direct ownership by 7% to 167,706 units (SEC Form 4)

    4 - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Issuer)

    11/3/25 6:00:14 PM ET
    $FTK
    Major Chemicals
    Industrials

    $FTK
    SEC Filings

    View All

    SEC Form 10-Q filed by Flotek Industries Inc.

    10-Q - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Filer)

    11/7/25 4:02:51 PM ET
    $FTK
    Major Chemicals
    Industrials

    Flotek Industries Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Filer)

    11/4/25 4:09:41 PM ET
    $FTK
    Major Chemicals
    Industrials

    SEC Form EFFECT filed by Flotek Industries Inc.

    EFFECT - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Filer)

    8/15/25 12:15:15 AM ET
    $FTK
    Major Chemicals
    Industrials

    $FTK
    Financials

    Live finance-specific insights

    View All

    Flotek Reports 95% Gross Profit Growth in Third Quarter

    HOUSTON, Nov. 4, 2025 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK), a leader in innovative energy solutions, today announced its financial results for the quarter and nine-months ended September 30, 2025, which reflect continued successful execution of its transformational strategy and robust growth across its two segments. Financial Summary (in thousands, except 'per share' amounts) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 % Change 2025 2024 % Change Total Revenues $      56,031 $      49,742 13 % $    169,74

    11/4/25 4:08:00 PM ET
    $FTK
    Major Chemicals
    Industrials

    Flotek Announces Third Quarter 2025 Earnings Release and Conference Call Schedule

    HOUSTON, Oct. 7, 2025 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK) today announced the Company's schedule for releasing its third quarter 2025 financial and operating results.    The Company plans to issue its third quarter 2025 financial and operating results press release after market close on Tuesday, November 4, 2025, and plans to host its earnings conference call on Wednesday, November 5, 2025, at 9:00 a.m. Central (10:00 a.m. Eastern). The press release will be posted on the Company's website at https://ir.flotekind.com/press-releases. P

    10/7/25 4:05:00 PM ET
    $FTK
    Major Chemicals
    Industrials

    Flotek Industries Reports Continued Growth in Revenue and Profitability, Fueled by 189% Growth in Data Analytics Revenue

    HOUSTON, Aug. 5, 2025 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK), a leader in innovative energy solutions, today announced its financial results for the quarter ended June 30, 2025, which reflect continued execution of its transformational strategy and robust growth across its two segments. Financial Summary (in thousands, except 'per share' amounts) Three Months Ended June 30, Six Months Ended June 30, 2025 2024 % Change 2025 2024 % Change Total Revenues $          58,350 $          46,152 26 % $       113,712 $          86,526 31 % Gross P

    8/5/25 4:05:00 PM ET
    $FTK
    Major Chemicals
    Industrials

    $FTK
    Leadership Updates

    Live Leadership Updates

    View All

    Flotek Set to Join the Russell Microcap® Index

    HOUSTON, June 11, 2024 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK) announced today that the company is set to join the Russell Microcap® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, 2024. The annual Russell US Indexes reconstitution captures the 4,000 largest US stocks as of Tuesday, April 30th, ranking them by total market capitalization. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in th

    6/11/24 9:00:00 AM ET
    $FTK
    Major Chemicals
    Industrials

    Flotek Enhances Executive Leadership Team With Addition of Leon Chad as Senior Vice President, Commercial

    HOUSTON, June 10, 2024 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK) today announced that it has appointed Leon Chad as Senior Vice President, Commercial, effective June 3, 2024. This appointment serves as the replacement for the Company's Senior Vice President- Global Business Lines who departed in March 2024. With over three decades of both domestic and international experience in the energy and chemistry industries, Mr. Chad brings invaluable expertise that will further enhance the Company's strategy to drive market share gains through its d

    6/10/24 4:15:00 PM ET
    $FTK
    Major Chemicals
    Industrials

    Flotek Strengthens Executive Leadership Team with the Addition of Amy Blakeway as Senior Vice President, General Counsel

    HOUSTON, March 4, 2024 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE:FTK) today announced that it has appointed Amy Blakeway as Senior Vice President, General Counsel, effective March 1, 2024. With over a decade of legal experience in the energy sector, Ms. Blakeway brings unique expertise that will further strengthen the leadership team and help advance the Company's growth strategy to drive market share gains through its differentiated chemistry and data solutions. Ryan Ezell, Chief Executive Officer, said, "I am pleased to welcome Amy as the newe

    3/4/24 4:15:00 PM ET
    $FTK
    Major Chemicals
    Industrials

    $FTK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by Flotek Industries Inc. (Amendment)

    SC 13D/A - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Subject)

    6/9/23 1:03:35 PM ET
    $FTK
    Major Chemicals
    Industrials

    SEC Form SC 13D/A filed by Flotek Industries Inc. (Amendment)

    SC 13D/A - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Subject)

    12/28/22 4:15:37 PM ET
    $FTK
    Major Chemicals
    Industrials

    SEC Form SC 13D/A filed by Flotek Industries Inc. (Amendment)

    SC 13D/A - FLOTEK INDUSTRIES INC/CN/ (0000928054) (Subject)

    8/29/22 4:13:00 PM ET
    $FTK
    Major Chemicals
    Industrials